Published by Josh White on 5th May 2026
(Sharecast News) - Fusion Antibodies said on Tuesday that full-year revenue rose and margins had improved sharply, as the pre-clinical antibody specialist made progress with platform development, grant-funded programmes and larger pharmaceutical customers.
URL: http://www.digitallook.com/dl/news/story/35909922/...